Andere Kunden interessierten sich auch für
![Bone marrow examination in pancytopenic patients]( "Bone marrow examination in pancytopenic patients")
Bone marrow examination in pancytopenic patients46,99 €![Synthesis and Test of Peptides and Peptoids for the Inhibition of Cytokines]( "Synthesis and Test of Peptides and Peptoids for the Inhibition of Cytokines")
Synthesis and Test of Peptides and Peptoids for the Inhibition of Cytokines56,00 €![Development of Functionalized Derivatives for the Application in a Novel Bioorthogonal Ligation Strategy and for the Design of IHF Mimicking Peptides]( "Development of Functionalized Derivatives for the Application in a Novel Bioorthogonal Ligation Strategy and for the Design of IHF Mimicking Peptides")
Development of Functionalized Derivatives for the Application in a Novel Bioorthogonal Ligation Strategy and for the Design of IHF Mimicking Peptides57,60 €![Hazardous Waste Operations and Emergency Response Manual]( "Hazardous Waste Operations and Emergency Response Manual")
Hazardous Waste Operations and Emergency Response Manual146,99 €![Response Surface Methodology in Optimization via Simulation]( "Response Surface Methodology in Optimization via Simulation")
Response Surface Methodology in Optimization via Simulation44,99 €![Prague, Czechoslovakia, August 29¿September 3, 1982]( "Prague, Czechoslovakia, August 29¿September 3, 1982")
Prague, Czechoslovakia, August 29¿September 3, 1982259,00 €![Response Surface Methodik in der Optimierung durch Simulation]( "Response Surface Methodik in der Optimierung durch Simulation")
Response Surface Methodik in der Optimierung durch Simulation68,90 €
Infection with hepatitis C virus is a serious worldwide problem which may lead to cirrhosis and hepatocellular carcinoma. The prevalence of HCV in Egypt is very high (about 20 % of the population). The only available treatment for HCV is the alpha interferon in combination with the guanosine analogue ribavirin. The immune response to this virus is insufficient in most infected individuals, thus the majority of whom develop chronic liver disease with viral persistence despite the presence of HCV-antibodies and cellular immune responses. Differences in the host cellular immune response to HCV may be important in viral clearance. The cellular immune response plays a major role in HCV infection and could represent an attractive target for therapeutic intervention.